drugset / Trial / NCT02488603

Decision Aids for Tamoxifen Treatment in Breast Cancer Patients

NCT02488603

Unknown 360 enrolled National Cancer Center, Korea
RandomizedParallel-groupSingle-blind

Summary

This is an educational intervention study for breast cancer patients who undergo tamoxifen treatment. The purpose of the study is to assess the impact of decision aids (DA) on the patients' decision-making process, compliance on drug, and knowledge regarding tamoxifen treatment. Patients will randomly assign to DA group or conventional group. Both groups will have baseline questionnaire surveys before starting tamoxifen treatment, and 4 weeks later follow-up questionnaire surveys.

Timeline

Start
2015-08
Primary completion
2018-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Tamoxifen Small molecule

Indications